The Second Coordination Sphere of FIH Controls Hydroxylation
The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn803 within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His2Asp) facial triad, αKG, and...
Saved in:
Published in | Biochemistry (Easton) Vol. 50; no. 21; pp. 4733 - 4740 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
31.05.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn803 within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His2Asp) facial triad, αKG, and H2O. Hydrogen bonding among the facial triad, the HIF-Asn803 side chain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn205 and Asn294) or HIF-Asn803-centered (Arg238 and Gln239) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O2, oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects; autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn205 → Ala and Asn294 → Ala mutants exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue-shifted metal to ligand charge transfer transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg238 → Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; the Arg238 → Met mutant was capable of O2 activation for the autohydroxylation reaction. The Gln239 → Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to the Gln239 → Asn mutant stimulated autohydroxylation, it is more likely that this point mutant simply mispositions the HIF-Asn803 side chain. This work combines kinetics and spectroscopy to show that these second-sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O2, and positioning HIF-Asn803. |
---|---|
AbstractList | The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn(803) within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His(2)Asp) facial triad, αKG, and H(2)O. Hydrogen bonding among the facial triad, the HIF-Asn(803) side chain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn(205) and Asn(294)) or HIF-Asn(803)-centered (Arg(238) and Gln(239)) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O(2), oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects; autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn(205) → Ala and Asn(294) → Ala mutants exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue-shifted metal to ligand charge transfer transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg(238) → Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; the Arg(238) → Met mutant was capable of O(2) activation for the autohydroxylation reaction. The Gln(239) → Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to the Gln(239) → Asn mutant stimulated autohydroxylation, it is more likely that this point mutant simply mispositions the HIF-Asn(803) side chain. This work combines kinetics and spectroscopy to show that these second-sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O(2), and positioning HIF-Asn(803). The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn803 within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His2Asp) facial triad, αKG, and H2O. Hydrogen bonding among the facial triad, the HIF-Asn803 side chain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn205 and Asn294) or HIF-Asn803-centered (Arg238 and Gln239) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O2, oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects; autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn205 → Ala and Asn294 → Ala mutants exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue-shifted metal to ligand charge transfer transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg238 → Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; the Arg238 → Met mutant was capable of O2 activation for the autohydroxylation reaction. The Gln239 → Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to the Gln239 → Asn mutant stimulated autohydroxylation, it is more likely that this point mutant simply mispositions the HIF-Asn803 side chain. This work combines kinetics and spectroscopy to show that these second-sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O2, and positioning HIF-Asn803. The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn(803) within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His(2)Asp) facial triad, αKG, and H(2)O. Hydrogen bonding among the facial triad, the HIF-Asn(803) side chain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn(205) and Asn(294)) or HIF-Asn(803)-centered (Arg(238) and Gln(239)) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O(2), oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects; autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn(205) → Ala and Asn(294) → Ala mutants exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue-shifted metal to ligand charge transfer transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg(238) → Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; the Arg(238) → Met mutant was capable of O(2) activation for the autohydroxylation reaction. The Gln(239) → Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to the Gln(239) → Asn mutant stimulated autohydroxylation, it is more likely that this point mutant simply mispositions the HIF-Asn(803) side chain. This work combines kinetics and spectroscopy to show that these second-sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O(2), and positioning HIF-Asn(803).The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn(803) within the α-subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG)-dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His(2)Asp) facial triad, αKG, and H(2)O. Hydrogen bonding among the facial triad, the HIF-Asn(803) side chain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn(205) and Asn(294)) or HIF-Asn(803)-centered (Arg(238) and Gln(239)) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O(2), oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects; autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn(205) → Ala and Asn(294) → Ala mutants exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue-shifted metal to ligand charge transfer transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg(238) → Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; the Arg(238) → Met mutant was capable of O(2) activation for the autohydroxylation reaction. The Gln(239) → Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to the Gln(239) → Asn mutant stimulated autohydroxylation, it is more likely that this point mutant simply mispositions the HIF-Asn(803) side chain. This work combines kinetics and spectroscopy to show that these second-sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O(2), and positioning HIF-Asn(803). The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn 803 within the α subunit of the hypoxia inducible factor (HIF). FIH is an α-ketoglutatrate (αKG) dependent, non-heme Fe(II) dioxygenase, in which Fe(II) is coordinated by a (His 2 Asp) facial triad, αKG, and H 2 O. Hydrogen bonding between the facial triad, the HIF-Asn 803 sidechain, and various second-sphere residues suggests a functional role for the second coordination sphere in tuning the chemistry of the Fe(II) center. Point mutants of FIH were prepared to test the functional role of the αKG-centered (Asn 205 , Asn 294 ) or HIF-Asn 803 centered (Arg 238 , Gln 239 ) second-sphere residues. The second sphere was tested for local effects on priming Fe(II) to react with O 2 , oxidative decarboxylation, and substrate positioning. Steady-sate kinetics were used to test for overall catalytic effects, autohydroxylation rates were used to test for priming and positioning, and electronic spectroscopy was used to assess the primary coordination sphere and the electrophilicity of αKG. Asn 205 →Ala and Asn 294 →Ala exhibited diminished rates of steady-state turnover, while minimally affecting autohydroxylation, consistent with impaired oxidative decarboxylation. Blue shifted MLCT transitions for (Fe+αKG)FIH indicated that these point mutations destabilized the π* orbitals of αKG, further supporting a slowed rate of oxidative decarboxylation. The Arg 238 →Met mutant exhibited steady-state rates too low to measure and diminished product yields, suggesting impaired substrate positioning or priming; Arg 238 →Met was capable of O 2 -activation for the autohydroxylation reaction. The Gln 239 →Asn mutant exhibited significantly slowed steady-state kinetics and diminished product yields, suggesting impaired substrate positioning or priming. As HIF binding to Gln 239 →Asn stimulated autohydroxylation, it is more likely that this point mutant simply mis-positions the HIF-Asn 803 sidechain. The present work combines kinetics and spectroscopy to show that these second sphere hydrogen bonds play roles in promoting oxidative decarboxylation, priming Fe(II) to bind O 2 , and positioning HIF-Asn 803 . |
Author | Saban, Evren Chen, Yuan-Han Knapp, Michael J A. Hangasky, John Holmes, Breanne E Y. Taabazuing, Cornelius |
AuthorAffiliation | Department of Chemistry Program in Molecular and Cellular Biology University of Massachusetts |
AuthorAffiliation_xml | – name: University of Massachusetts – name: Department of Chemistry – name: Program in Molecular and Cellular Biology – name: 2 Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, MA, 01003 – name: 1 Department of Chemistry, University of Massachusetts, Amherst, MA, 01003 |
Author_xml | – sequence: 1 givenname: Evren surname: Saban fullname: Saban, Evren – sequence: 2 givenname: Yuan-Han surname: Chen fullname: Chen, Yuan-Han – sequence: 3 givenname: John surname: A. Hangasky fullname: A. Hangasky, John – sequence: 4 givenname: Cornelius surname: Y. Taabazuing fullname: Y. Taabazuing, Cornelius – sequence: 5 givenname: Breanne E surname: Holmes fullname: Holmes, Breanne E – sequence: 6 givenname: Michael J surname: Knapp fullname: Knapp, Michael J email: mknapp@chem.umass.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21456582$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtLAzEUhYMoWh8L_4DMRsTF2CSTZDIgghS1hYILdR0yScZGpklNpmL_vbEvVFwdwv3uOeHcQ7DrvDMAnCJ4hSBG_domgQR3O6CHKIY5qSq6C3oQQpbjisEDcBjjW3oSWJJ9cIARoYxy3APXzxOTPRnlnc4G3gdtneysd9nTbGKCyXyT3Y-GaeS64NuYDRc6-M9Fu4SOwV4j22hO1noEXu7vngfDfPz4MBrcjnNJIOnyWissqSlLTUhZ8YpozZmum4KxWhGF64ZySWta8BLzhhSqqQ1FSHOYREtdHIGble9sXk-NViZ9RrZiFuxUhoXw0orfE2cn4tV_iAIVnJQ4GVysDYJ_n5vYiamNyrStdMbPo-CMM0xSdYk8-xm1zdg0loD-ClDBxxhMI5Ttlm2kZNsKBMX3TcT2Jmnj8s_GxvQ_9nzFShXFm58Hl3r9h_sCuaqYcg |
CitedBy_id | crossref_primary_10_1021_acs_biochem_3c00231 crossref_primary_10_1021_bi3015482 crossref_primary_10_1021_bi501246v crossref_primary_10_1038_s41589_021_00944_x crossref_primary_10_1016_j_ica_2020_119559 crossref_primary_10_1021_acscatal_3c02531 crossref_primary_10_1016_j_jinorgbio_2016_10_007 crossref_primary_10_1021_ic502658p crossref_primary_10_1021_bi500703s crossref_primary_10_1016_j_jinorgbio_2013_12_010 crossref_primary_10_1021_ja312571m crossref_primary_10_1021_jacs_4c15153 crossref_primary_10_1016_j_jinorgbio_2012_03_002 crossref_primary_10_1016_j_ccr_2021_214358 crossref_primary_10_1021_bi300229y crossref_primary_10_1093_mtomcs_mfab056 crossref_primary_10_1021_acs_inorgchem_1c01754 crossref_primary_10_1021_acs_biochem_2c00115 crossref_primary_10_1021_acs_biochem_5b01003 crossref_primary_10_1021_acs_inorgchem_1c00468 crossref_primary_10_1021_acs_biochem_6b00635 crossref_primary_10_1021_acs_inorgchem_0c03441 crossref_primary_10_1021_acs_biochem_9b00619 crossref_primary_10_1039_c3mt20153h |
Cites_doi | 10.1074/jbc.M210385200 10.1042/BJ20061151 10.1016/0003-9861(74)90298-7 10.1021/ja039113j 10.1039/b810957e 10.1021/bi048746n 10.1042/bj20021162 10.1021/ja983534x 10.1021/ja909416z 10.1038/nchembio863 10.1021/bi0507579 10.1016/S1359-6446(04)03202-7 10.1111/j.1432-1033.1997.t01-1-00625.x 10.1021/ja004025+ 10.1152/physiol.00001.2004 10.1016/j.jinorgbio.2008.07.018 10.1021/ja037400h 10.1021/bi991796l 10.1016/j.jinorgbio.2011.01.007 10.1021/bi002893d 10.1126/science.1066373 10.1021/cr9900275 10.1006/abio.1997.2236 10.1074/jbc.M901790200 10.1074/jbc.M312254200 10.1111/j.1742-4658.2010.07804.x 10.1021/bi9912746 10.1089/ars.2009.2711 10.1021/ja972408a 10.1039/b809099h 10.1080/10409230490440541 10.1021/bi030011f 10.1074/jbc.C200644200 10.1074/jbc.M313614200 10.1021/ja964449x 10.1016/j.jinorgbio.2007.03.018 10.1073/pnas.202614999 10.1021/ja028867f 10.1016/0022-5193(82)90320-4 10.1021/ar700237u |
ContentType | Journal Article |
Copyright | Copyright © 2011 American Chemical Society |
Copyright_xml | – notice: Copyright © 2011 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1021/bi102042t |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1520-4995 |
EndPage | 4740 |
ExternalDocumentID | PMC3138472 21456582 10_1021_bi102042t a149481386 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
GrantInformation | Supported by National Institutes of Health Grant R01-GM077413. |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R01-GM077413 – fundername: NIGMS NIH HHS grantid: T32 GM008515 – fundername: NIGMS NIH HHS grantid: R01 GM077413 |
GroupedDBID | - .K2 02 23N 3O- 4.4 53G 55 55A 5GY 5RE 5VS 7~N 85S AABXI ABFLS ABMVS ABOCM ABPTK ABUCX ABUFD ACGFS ACJ ACNCT ACS AEESW AENEX AFEFF AJYGW ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 D0L DU5 DZ EBS ED ED~ EJD F5P GNL IH9 IHE JG JG~ K2 KM L7B LG6 P2P ROL TN5 UI2 VF5 VG9 VQA W1F WH7 X X7M YZZ ZA5 --- -DZ -~X .55 AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AGXLV AHGAQ CITATION CUPRZ GGK XSW ZCA ~02 ~KM CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-a404t-bdc2a5e77d4479894dd86dbf366bc4c2bf58a5b538728f43cfbe511d80e51dad3 |
IEDL.DBID | ACS |
ISSN | 0006-2960 1520-4995 |
IngestDate | Thu Aug 21 18:20:47 EDT 2025 Fri Jul 11 01:53:24 EDT 2025 Mon Jul 21 06:04:03 EDT 2025 Thu Apr 24 22:59:11 EDT 2025 Tue Jul 01 02:05:55 EDT 2025 Thu Aug 27 13:43:10 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a404t-bdc2a5e77d4479894dd86dbf366bc4c2bf58a5b538728f43cfbe511d80e51dad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3138472 |
PMID | 21456582 |
PQID | 868624152 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3138472 proquest_miscellaneous_868624152 pubmed_primary_21456582 crossref_citationtrail_10_1021_bi102042t crossref_primary_10_1021_bi102042t acs_journals_10_1021_bi102042t |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-31 |
PublicationDateYYYYMMDD | 2011-05-31 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biochemistry (Easton) |
PublicationTitleAlternate | Biochemistry |
PublicationYear | 2011 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | Ozer A. (ref2/cit2) 2007; 3 Solomon E. I. (ref10/cit10) 2000; 100 Nagel S. (ref8/cit8) 2010; 12 Koivunen P. (ref30/cit30) 2004; 279 Hegg E. L. (ref36/cit36) 1999; 38 Zhou J. (ref19/cit19) 2001; 123 Dann C. E. (ref11/cit11) 2002; 99 Mehn M. P. (ref41/cit41) 2003; 125 Bleijlevens B. (ref35/cit35) 2007; 101 Walsh C. T. (ref20/cit20) 1979 Chen Y. H. (ref23/cit23) 2008; 102 Plotnikov V. V. (ref24/cit24) 1997; 250 Zhou J. (ref33/cit33) 1998; 120 Ehrismann D. (ref29/cit29) 2007; 401 Hendrich M. P. (ref44/cit44) 2010 Bruick R. K. (ref1/cit1) 2001; 294 Miller A. F. (ref16/cit16) 2008; 41 Chen Y. H. (ref28/cit28) 2008 Hewitson K. S. (ref7/cit7) 2004; 9 Pavel E. G. (ref18/cit18) 1998; 120 Semenza G. L. (ref3/cit3) 2004; 19 Mole D. R. (ref4/cit4) 2009; 284 Price J. C. (ref39/cit39) 2003; 125 Peisach J. (ref34/cit34) 1974; 165 Lee C. (ref13/cit13) 2003; 278 Proshlyakov D. A. (ref22/cit22) 2004; 126 Martell A. E. (ref27/cit27) 1974 (ref25/cit25) 2010 Tomchick D. R. (ref15/cit15) 2001; 40 Shook R. L. (ref14/cit14) 2008 Mills S. A. (ref26/cit26) 2005; 44 Hanauske-Abel H. M. (ref6/cit6) 1982; 94 McNeill L. A. (ref5/cit5) 2002; 367 Grzyska P. K. (ref38/cit38) 2005; 44 Elkins J. M. (ref12/cit12) 2003; 278 Flashman E. (ref40/cit40) 2010; 277 Ryle M. J. (ref32/cit32) 1999; 38 Saban E. (ref43/cit43) 2011; 105 Hausinger R. P. (ref9/cit9) 2004; 39 Whiting A. K. (ref37/cit37) 1997; 119 McCusker K. P. (ref42/cit42) 2010; 132 Linke S. (ref31/cit31) 2004; 279 Hegg E. L. (ref17/cit17) 1997; 250 Price J. C. (ref21/cit21) 2003; 42 |
References_xml | – volume: 278 start-page: 7558 year: 2003 ident: ref13/cit13 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M210385200 – volume: 401 start-page: 227 year: 2007 ident: ref29/cit29 publication-title: Biochem. J. doi: 10.1042/BJ20061151 – volume-title: Enzymatic Reaction Mechanisms year: 1979 ident: ref20/cit20 – volume: 165 start-page: 691 year: 1974 ident: ref34/cit34 publication-title: Arch. Biochem. Biophys. doi: 10.1016/0003-9861(74)90298-7 – volume: 126 start-page: 1022 year: 2004 ident: ref22/cit22 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja039113j – start-page: 6095 year: 2008 ident: ref14/cit14 publication-title: Chem. Commun., doi: 10.1039/b810957e – volume: 44 start-page: 3845 year: 2005 ident: ref38/cit38 publication-title: Biochemistry doi: 10.1021/bi048746n – volume: 367 start-page: 571 year: 2002 ident: ref5/cit5 publication-title: Biochem. J. doi: 10.1042/bj20021162 – volume: 120 start-page: 13539 year: 1998 ident: ref33/cit33 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja983534x – volume: 132 start-page: 5114 year: 2010 ident: ref42/cit42 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja909416z – volume: 3 start-page: 144 year: 2007 ident: ref2/cit2 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio863 – volume-title: Spincount year: 2010 ident: ref44/cit44 – volume: 44 start-page: 13553 year: 2005 ident: ref26/cit26 publication-title: Biochemistry doi: 10.1021/bi0507579 – volume: 9 start-page: 704 year: 2004 ident: ref7/cit7 publication-title: Drug Discovery Today doi: 10.1016/S1359-6446(04)03202-7 – volume: 250 start-page: 625 year: 1997 ident: ref17/cit17 publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1997.t01-1-00625.x – volume: 123 start-page: 7388 year: 2001 ident: ref19/cit19 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja004025+ – volume: 19 start-page: 176 year: 2004 ident: ref3/cit3 publication-title: Physiology doi: 10.1152/physiol.00001.2004 – volume: 102 start-page: 2120 year: 2008 ident: ref23/cit23 publication-title: J. Inorg. Biochem. doi: 10.1016/j.jinorgbio.2008.07.018 – volume: 125 start-page: 13008 year: 2003 ident: ref39/cit39 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja037400h – volume: 38 start-page: 16714 year: 1999 ident: ref36/cit36 publication-title: Biochemistry doi: 10.1021/bi991796l – volume: 105 start-page: 630 year: 2011 ident: ref43/cit43 publication-title: J. Inorg. Biochem. doi: 10.1016/j.jinorgbio.2011.01.007 – volume: 40 start-page: 7509 year: 2001 ident: ref15/cit15 publication-title: Biochemistry doi: 10.1021/bi002893d – volume: 294 start-page: 1337 year: 2001 ident: ref1/cit1 publication-title: Science doi: 10.1126/science.1066373 – volume: 100 start-page: 235 year: 2000 ident: ref10/cit10 publication-title: Chem. Rev. doi: 10.1021/cr9900275 – volume: 250 start-page: 237 year: 1997 ident: ref24/cit24 publication-title: Anal. Biochem. doi: 10.1006/abio.1997.2236 – volume: 284 start-page: 16767 year: 2009 ident: ref4/cit4 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M901790200 – volume: 279 start-page: 9899 year: 2004 ident: ref30/cit30 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M312254200 – volume: 277 start-page: 4089 year: 2010 ident: ref40/cit40 publication-title: FEBS J. doi: 10.1111/j.1742-4658.2010.07804.x – volume: 38 start-page: 15278 year: 1999 ident: ref32/cit32 publication-title: Biochemistry doi: 10.1021/bi9912746 – volume: 12 start-page: 481 year: 2010 ident: ref8/cit8 publication-title: Antioxid. Redox Signaling doi: 10.1089/ars.2009.2711 – volume: 120 start-page: 743 year: 1998 ident: ref18/cit18 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja972408a – start-page: 4768 year: 2008 ident: ref28/cit28 publication-title: Chem. Commun., doi: 10.1039/b809099h – volume: 39 start-page: 21 year: 2004 ident: ref9/cit9 publication-title: Crit. Rev. Biochem. Mol. Biol. doi: 10.1080/10409230490440541 – volume: 42 start-page: 7497 year: 2003 ident: ref21/cit21 publication-title: Biochemistry doi: 10.1021/bi030011f – volume: 278 start-page: 1802 year: 2003 ident: ref12/cit12 publication-title: J. Biol. Chem. doi: 10.1074/jbc.C200644200 – volume: 279 start-page: 14391 year: 2004 ident: ref31/cit31 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M313614200 – volume: 119 start-page: 3413 year: 1997 ident: ref37/cit37 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja964449x – volume: 101 start-page: 1043 year: 2007 ident: ref35/cit35 publication-title: J. Inorg. Biochem. doi: 10.1016/j.jinorgbio.2007.03.018 – volume: 99 start-page: 15351 year: 2002 ident: ref11/cit11 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.202614999 – volume: 125 start-page: 7828 year: 2003 ident: ref41/cit41 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja028867f – volume-title: Critical Stability Constants year: 1974 ident: ref27/cit27 – volume: 94 start-page: 421 year: 1982 ident: ref6/cit6 publication-title: J. Theor. Biol. doi: 10.1016/0022-5193(82)90320-4 – volume-title: Origin year: 2010 ident: ref25/cit25 – volume: 41 start-page: 501 year: 2008 ident: ref16/cit16 publication-title: Acc. Chem. Res. doi: 10.1021/ar700237u |
SSID | ssj0004074 |
Score | 2.155846 |
Snippet | The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn803 within the α-subunit of the hypoxia inducible factor (HIF).... The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn(803) within the α-subunit of the hypoxia inducible factor... The factor inhibiting HIF (FIH) is a proximate oxygen sensor for human cells, hydroxylating Asn 803 within the α subunit of the hypoxia inducible factor (HIF).... |
SourceID | pubmedcentral proquest pubmed crossref acs |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4733 |
SubjectTerms | Animals Calorimetry, Differential Scanning Electron Spin Resonance Spectroscopy Hydroxylation Mice Mixed Function Oxygenases - chemistry Mixed Function Oxygenases - physiology Models, Molecular Point Mutation Recombinant Proteins - chemistry Recombinant Proteins - metabolism Spectrophotometry, Ultraviolet |
Title | The Second Coordination Sphere of FIH Controls Hydroxylation |
URI | http://dx.doi.org/10.1021/bi102042t https://www.ncbi.nlm.nih.gov/pubmed/21456582 https://www.proquest.com/docview/868624152 https://pubmed.ncbi.nlm.nih.gov/PMC3138472 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT-MwEB4Be1guPMqrvGSxaMUl0DhO4kpcqkBVkNhLQeIW-SkqIEU0PZRfzziPLoWye8rBYyv2TDLf2DOfAY59FVCjfN-Tym97TIShh5Ft29OBZYLFUirhaodv_kS9O3Z9H94vwK9vTvCpfyYHvivgpPki_KARj12E1Un6f4sfWxXVMobGFPF4TR_0satzPWo063q-4MnPaZEf_Ex3FS7qap0yveTxdJzLU_X2lbzxX1NYg5UKZ5JOaRjrsGCyBmx0MoyxnyfkNykyP4st9Qb8TOpb3zbgHO2G9F2UrEkyxMh0UG4Xkr7jHzBkaEn3qkeSMsN9RHoT7d60zKjbhLvu5W3S86obFjzBWiz3pFZUhCaONWOxo2LXmkda2iCKpGKKShtyEUr8KcaUWxYoKw0iNM1b-NBCB1uwlA0zswPEUkQGCC-4jVHHUVtobjkOEjJjVMhsEw5RBWn1hYzS4vCb-ul0bZpwUmsnVRU_ubsm42me6NFU9KUk5ZgnRGoVp7iG7hxEZGY4HqW8qIpB4NKE7VLj01EcbztiMmyJZ2xhKuDYuGdbssFDwcod-AF6err7v3nuwXK5L-0yEPZhKX8dmwMENrk8LAz7HSPj8so |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT-MwEB4t7AEuvB_ltRZarfYSaBznUYlLFVGF5XEpSNwiP0UFpIikh_LrGTtpoSwSnHLwxLI9k8w39sxngN--DKiWvu8J6Xc8xsPQw8i246nAMM5iISS3tcOXV1F2w_7dhrcNTY6thcFBlNhT6Q7x39gF_GMx8G0dJ63m4CeCEGoDrW7af6uBbDeMyxghU4TlExah969aDyTLWQ_0H6z8mB35zt30lut7i9xAXZbJ_dGoEkfy5QOH4_dmsgJLDeok3dpMVuGHLtZgvVtgxP04Jn-IywN1G-xrsJBO7oBbhxO0ItK3MbMi6RDj1EG9eUj6lo1Ak6EhvbOMpHW-e0mysbIDrvPrNuCmd3qdZl5z34LHWZtVnlCS8lDHsWIstsTsSiWREiaIIiGZpMKECQ8F_iJjmhgWSCM04jWVtPGhuAo2Yb4YFnobiKGIExBsJCZGjUcdrhKTYCch01qGzLTgAJcmb76XMndH4dTPp2vTgr8TJeWyYSu3l2Y8fCZ6OBV9qik6PhMiE03nuIb2VIQXejgq88TVyCCMacFWrfhpL5bFHREatsQzJjEVsNzcsy3F4M5xdAd-gH6f7nw1z1-wkF1fXuQXZ1fnu7BY71jb3IQ9mK-eR3ofIU8lDpytvwKunvsr |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swED9tRdr2AqyMrcA6a5qmvaQ0jvNRiZcqW9XCxiZ1lXiL_CkqWFqR9KH89ZyTNNAOCZ7y4Ivl-Ozc73x3PwN8caVHtXRdR0i35zDu-w56tj1HeYZxFgohua0d_nUeDCfs9MK_qBxFWwuDg8iwp6wI4ttdPVemYhhwj8XUtbWcNH8JWzZcZ52tfjy-r4PsVqzL6CVThOYrJqGHr1orJLN1K_QftNzMkHxgcgY78LsebJFpctVZ5KIjbzd4HJ__NbuwXaFP0i-Xy1t4odMm7PVT9Lz_LclXUuSDFgftTXgdr-6C24MTXE1kbH1nReIZ-qvT8hCRjC0rgSYzQwajIYnLvPeMDJfKDrrMs3sHk8GPv_HQqe5dcDjrstwRSlLu6zBUjIWWoF2pKFDCeEEgJJNUGD_ivsBfZUgjwzxphEbcpqIuPhRX3j400lmqPwAxFPECgo7IhKj5oMdVZCLsxGdaS5-ZFrRxepJq32RJERKnblLPTQu-rRSVyIq13F6ecf2Y6OdadF5SdTwmRFbaTnAObXSEp3q2yJKoqJVBONOC96Xy614smzsiNWwJ15ZFLWA5utdb0ullwdXtuR7af3rw1Hd-gld_vg-Sn6Pzs0N4Ux5c2xSFI2jkNwv9EZFPLtrFcr8D2yf9rg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+second+coordination+sphere+of+FIH+controls+hydroxylation&rft.jtitle=Biochemistry+%28Easton%29&rft.au=Saban%2C+Evren&rft.au=Chen%2C+Yuan-Han&rft.au=Hangasky%2C+John&rft.au=Taabazuing%2C+Cornelius&rft.date=2011-05-31&rft.issn=0006-2960&rft.eissn=1520-4995&rft.volume=50&rft.issue=21&rft.spage=4733&rft.epage=4740&rft_id=info:doi/10.1021%2Fbi102042t&rft_id=info%3Apmid%2F21456582&rft.externalDocID=PMC3138472 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2960&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2960&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2960&client=summon |